Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Regulation of Id1 expression by SRC: implications for targeting of the bone morphogenetic protein pathway in cancer.

Gautschi O, Tepper CG, Purnell PR, Izumiya Y, Evans CP, Green TP, Desprez PY, Lara PN, Gandara DR, Mack PC, Kung HJ.

Cancer Res. 2008 Apr 1;68(7):2250-8. doi: 10.1158/0008-5472.CAN-07-6403.

2.

Serum regulation of Id1 expression by a BMP pathway and BMP responsive element.

Lewis TC, Prywes R.

Biochim Biophys Acta. 2013 Oct;1829(10):1147-59. doi: 10.1016/j.bbagrm.2013.08.002. Epub 2013 Aug 13.

3.

Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis.

Katagiri T, Imada M, Yanai T, Suda T, Takahashi N, Kamijo R.

Genes Cells. 2002 Sep;7(9):949-60.

4.

Upregulation of ID protein by growth and differentiation factor 5 (GDF5) through a smad-dependent and MAPK-independent pathway in HUVSMC.

Chen X, Zankl A, Niroomand F, Liu Z, Katus HA, Jahn L, Tiefenbacher C.

J Mol Cell Cardiol. 2006 Jul;41(1):26-33. Epub 2006 May 22.

PMID:
16716349
5.

Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts.

Nakashima A, Katagiri T, Tamura M.

J Biol Chem. 2005 Nov 11;280(45):37660-8. Epub 2005 Sep 2.

6.

MicroRNA-29b is involved in the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma.

Rothschild SI, Tschan MP, Federzoni EA, Jaggi R, Fey MF, Gugger M, Gautschi O.

Oncogene. 2012 Sep 20;31(38):4221-32. doi: 10.1038/onc.2011.578. Epub 2012 Jan 16.

PMID:
22249264
7.

Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene.

López-Rovira T, Chalaux E, Massagué J, Rosa JL, Ventura F.

J Biol Chem. 2002 Feb 1;277(5):3176-85. Epub 2001 Nov 7.

8.

HLA-B-associated transcript 3 (Bat3/Scythe) negatively regulates Smad phosphorylation in BMP signaling.

Goto K, Tong KI, Ikura J, Okada H.

Cell Death Dis. 2011 Dec 1;2:e236. doi: 10.1038/cddis.2011.114.

9.

Inhibition of BMP and of TGFβ receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death.

Augeri DJ, Langenfeld E, Castle M, Gilleran JA, Langenfeld J.

Mol Cancer. 2016 Apr 6;15:27. doi: 10.1186/s12943-016-0511-9.

10.

Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.

Yang J, Davies RJ, Southwood M, Long L, Yang X, Sobolewski A, Upton PD, Trembath RC, Morrell NW.

Circ Res. 2008 May 23;102(10):1212-21. doi: 10.1161/CIRCRESAHA.108.173567. Epub 2008 Apr 24.

11.

WSS25 inhibits growth of xenografted hepatocellular cancer cells in nude mice by disrupting angiogenesis via blocking bone morphogenetic protein (BMP)/Smad/Id1 signaling.

Qiu H, Yang B, Pei ZC, Zhang Z, Ding K.

J Biol Chem. 2010 Oct 15;285(42):32638-46. doi: 10.1074/jbc.M110.105544. Epub 2010 Aug 2.

13.

Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells.

Valdimarsdottir G, Goumans MJ, Rosendahl A, Brugman M, Itoh S, Lebrin F, Sideras P, ten Dijke P.

Circulation. 2002 Oct 22;106(17):2263-70.

14.

Nuclear factor YY1 inhibits transforming growth factor beta- and bone morphogenetic protein-induced cell differentiation.

Kurisaki K, Kurisaki A, Valcourt U, Terentiev AA, Pardali K, Ten Dijke P, Heldin CH, Ericsson J, Moustakas A.

Mol Cell Biol. 2003 Jul;23(13):4494-510.

15.

Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2.

Sowa H, Kaji H, Hendy GN, Canaff L, Komori T, Sugimoto T, Chihara K.

J Biol Chem. 2004 Sep 24;279(39):40267-75. Epub 2004 May 18.

16.

Nicotine-mediated invasion and migration of non-small cell lung carcinoma cells by modulating STMN3 and GSPT1 genes in an ID1-dependent manner.

Nair S, Bora-Singhal N, Perumal D, Chellappan S.

Mol Cancer. 2014 Jul 16;13:173. doi: 10.1186/1476-4598-13-173.

17.

Cyclic AMP enhances Smad-mediated BMP signaling through PKA-CREB pathway.

Ohta Y, Nakagawa K, Imai Y, Katagiri T, Koike T, Takaoka K.

J Bone Miner Metab. 2008;26(5):478-84. doi: 10.1007/s00774-008-0850-8. Epub 2008 Aug 30.

PMID:
18758906
18.

WSS25, a sulfated polysaccharide, inhibits RANKL-induced mouse osteoclast formation by blocking SMAD/ID1 signaling.

Chen C, Qin Y, Fang JP, Ni XY, Yao J, Wang HY, Ding K.

Acta Pharmacol Sin. 2015 Sep;36(9):1053-64. doi: 10.1038/aps.2015.65. Epub 2015 Aug 24.

19.
20.

Supplemental Content

Support Center